Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 63.03 Million TWD | -13.05% |
| 2022 | 72.49 Million TWD | 29.03% |
| 2021 | 56.18 Million TWD | -4.63% |
| 2020 | 58.9 Million TWD | 9.55% |
| 2019 | 53.77 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 68.22 Million TWD | 0.0% |
| 2024 Q1 | 68.22 Million TWD | 8.24% |
| 2023 Q1 | 82.92 Million TWD | 14.4% |
| 2023 FY | 63.03 Million TWD | -13.05% |
| 2023 Q4 | 63.03 Million TWD | 0.0% |
| 2023 Q3 | 63.03 Million TWD | -23.99% |
| 2023 Q2 | 82.92 Million TWD | 0.0% |
| 2022 Q4 | 72.49 Million TWD | 0.0% |
| 2022 FY | 72.49 Million TWD | 29.03% |
| 2022 Q3 | 72.49 Million TWD | 0.0% |
| 2021 FY | 56.18 Million TWD | -4.63% |
| 2020 FY | 58.9 Million TWD | 9.55% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 49.463% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 82.887% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -690.692% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 80.81% |
| NaviFUS Corp. | 53.4 Million TWD | -18.039% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 47.41% |
| TaiRx, Inc. | 60.62 Million TWD | -3.974% |
| Sinew Pharma Inc. | 39.71 Million TWD | -58.72% |
| Lin BioScience, Inc. | 167.73 Million TWD | 62.419% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -852.463% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 72.316% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -801.258% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 89.197% |
| AP Biosciences Inc | 106.65 Million TWD | 40.896% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 91.4% |
| RBC Bioscience Corporation | 513.08 Million TWD | 87.715% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 93.533% |
| EirGenix Inc. | 1.14 Billion TWD | 94.495% |
| Enimmune corporation | 173.46 Million TWD | 63.661% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 60.863% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -49.518% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -105.45% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 95.253% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 95.236% |
| TCI GENE Inc. | 155.54 Million TWD | 59.476% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -196.966% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 92.725% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -579.539% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 68.079% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -12.938% |
| Neith Corporation | 17.43 Million TWD | -261.579% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 87.699% |
| VBI | 21.25 Million TWD | -196.617% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 72.942% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 79.907% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -171.056% |
| CHO Pharma, Inc. | 110.83 Million TWD | 43.127% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -8.606% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -147.115% |
| Visgeneer Inc. | 185.6 Million TWD | 66.039% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 82.706% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 43.71% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 86.908% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 54.265% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 32.738% |
| GlycoNex Incorporation | 276.39 Million TWD | 77.195% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.214% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 67.838% |
| PharmaEngine, Inc. | 91 Million TWD | 30.736% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 95.915% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 87.752% |
| BiOptic Inc. | 170.56 Million TWD | 63.044% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 43.182% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -36.511% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 2.856% |
| OBI Pharma, Inc. | 650.44 Million TWD | 90.309% |
| Savior Lifetec Corporation | 457.95 Million TWD | 86.236% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -135.087% |
| Level Biotechnology Inc. | 273.2 Million TWD | 76.928% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.194% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 83.871% |
| Acepodia, Inc. | 384.47 Million TWD | 83.605% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 26.322% |